Number of the records: 1
tolkapón
SYS d000077867 LBL 00000nz--a2200181n--4500 005 20250606222657.4 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D02.455.426.559.389.134.875 065 $a D02.455.426.559.389.657.566.845 065 $a D02.522.223.875 065 $a D02.640.743.845 066 $a 01 $c 03 150 $a tolkapón $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a 3,4-dihydroxy-5'-metyl-5-nitrobenzofenón $2 slo 450 $w v $a Tasmar $2 slo 550 $7 sllk_us_auth*d000978 $Y Antiparkinson Agents $w P $a antiparkinsoniká 550 $7 sllk_us_auth*d065098 $Y Catechol O-Methyltransferase Inhibitors $w P $a inhibítory katechol-O-metyltransferázy 665 $a 2019 (1990) $2 eng 680 9-
$i A benzophenone and nitrophenol compound that acts as an inhibitor of CATECHOL O-METHYLTRANSFERASE, an enzyme involved in the metabolism of DOPAMINE and LEVODOPA. It is used in the treatment of PARKINSON DISEASE in patients for whom levodopa is ineffective or contraindicated. $2 eng 750 -2
$a Tolcapone $2 eng 980 $x M
Number of the records: 1